138 related articles for article (PubMed ID: 31901863)
1. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
[TBL] [Abstract][Full Text] [Related]
2. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
[TBL] [Abstract][Full Text] [Related]
5. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
7. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
8. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Huang Z; Zhou B; Li Z; Liu C; Zheng C; Zeng R; Hong C; Xu L; Li E; Peng Y; Xu Y
Cancer Biomark; 2020; 29(1):139-149. PubMed ID: 32623391
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
[TBL] [Abstract][Full Text] [Related]
14. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
Chen J; Chen M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
[TBL] [Abstract][Full Text] [Related]
15. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
[TBL] [Abstract][Full Text] [Related]
16. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
17. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma.
Huang X; Hong C; Peng Y; Yang S; Huang L; Liu C; Chen L; Chu L; Xu L; Xu Y
J Cancer; 2019; 10(12):2687-2693. PubMed ID: 31258777
[TBL] [Abstract][Full Text] [Related]
19. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
[TBL] [Abstract][Full Text] [Related]
20. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
